| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $2,369,583 ) |
| | 2025 | 2025 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R42MD018231 | Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | 003 | 2 | NIH | 9/11/2025 | $472,918 |
| | 2025 | 2025 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R42MD018231 | Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | 000 | 2 | NIH | 11/28/2024 | $885,429 |
| | 2025 | 2025 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R42MD018231 | Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | 002 | 2 | NIH | 4/28/2025 | $98,378 |
| | 2025 | 2025 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA281719 | Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | 001 | 2 | NIH | 5/14/2025 | $912,858 |
| | 2025 | 2024 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R42MD018231 | Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | 001 | 1 | NIH | 4/22/2025 | $0 |
| | 2025 | 2023 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA281719 | Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | 000 | 1 | NIH | 3/7/2025 | $0 |
| | 2025 | 2023 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA254690 | Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | 000 | 3 | NIH | 7/31/2025 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $275,767 ) |
| | 2024 | 2024 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R42MD018231 | Precision screening in self-collected samples to reduce cervical cancer disparities among Latinas | 000 | 1 | NIH | 4/22/2024 | $275,767 |
|
| Issue Date FY: 2023 ( Subtotal = $1,292,486 ) |
| | 2023 | 2023 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA281719 | Precision DNA methylation test to reduce oral cancer disparities in African Americans patients residing in low-resource settings | 000 | 1 | NIH | 9/20/2023 | $292,486 |
| | 2023 | 2023 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA254690 | Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | 000 | 3 | NIH | 5/2/2023 | $1,000,000 |
| | 2023 | 2021 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 000 | 3 | NIH | 1/23/2023 | $0 |
| | 2023 | 2021 | LIFEGENE- BIOMARKS INC | 1612 AVE PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA254690 | Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | 001 | 1 | NIH | 5/15/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $1,000,000 ) |
| | 2022 | 2022 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA254690 | Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | 000 | 2 | NIH | 7/15/2022 | $1,000,000 |
|
| Issue Date FY: 2021 ( Subtotal = $1,133,760 ) |
| | 2021 | 2021 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 001 | 3 | NIH | 4/30/2021 | $733,762 |
| | 2021 | 2021 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44CA254690 | Precision methylation biomarkers for cervical cancer prevention in low resource settings in Latin America | 000 | 1 | NIH | 9/20/2021 | $399,998 |
| | 2021 | 2019 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 000 | 1 | NIH | 11/17/2020 | $0 |
|
| Issue Date FY: 2020 ( Subtotal = $802,513 ) |
| | 2020 | 2020 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 000 | 2 | NIH | 6/23/2020 | $802,513 |
| | 2020 | 2020 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 002 | 2 | NIH | 6/25/2020 | $0 |
| | 2020 | 2019 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 001 | 1 | NIH | 6/25/2020 | $0 |
|
| Issue Date FY: 2019 ( Subtotal = $206,042 ) |
| | 2019 | 2019 | LIFEGENE- BIOMARKS, INC | 1612 AVENIDA PONCE DE LEON | SAN JUAN | PR | 00909-1833 | SAN JUAN | USA | R44MD014911 | Precision methylation biomarkers linked to cancer disparities | 000 | 1 | NIH | 9/24/2019 | $206,042 |
|
|
